Neurological Biomarkers Market Report

Neurological Biomarkers Market Analysis, Market Size, Product Analysis, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2026

  • Published Date: ---
  • Base Year for Estimate: ---
  • Report ID: GVR6267
  • Format: Electronic (PDF)
  • Historical Data: ---
  • Number of Pages: 0

The global neurological biomarkers market is projected to exhibit strong growth through the forecast period, driven by an increasing global burden of neurological diseases and technological advancements. Proactive government initiatives and steady growth in consumer awareness are likely to promote higher growth in this market.

There exists an unmet market need for early diagnosis of neurological diseases. Neurological biomarkers could provide significant prognostic and predictive value additions to current diagnosis paradigms. Furthermore, rising trend of personalized medicines in neurological treatments is anticipated to positively influence market growth.

Neurological biomarkers could be applied into the following indications: Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, autism spectrum disorders, Huntington’s disease, schizophrenia, and glioma - among others. Some of the most prevalent neurological disorders - such as Alzheimer’s disease and Parkinson’s disease - are progressive neurodegenerative disorders, in an urgent need of early & accurate diagnosis.

Neurological biomarkers could belong to genomic, proteomic, metabolomic, and imaging types. Technological advancements have made it possible to diagnose and treat neurological diseases in a more personalized manner based on an individual’s genetic predisposition and variations. Techniques - such as single nucleotide polymorphism, comparative genome hybridizations, and gene profiling - are forecasted to be significant revenue generators for genomic neurologic biomarkers.

Geographically, the market has been divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Some of the major players in the global neurological biomarkers market include Abbott; QIAGEN; Myriad RBM; Thermo Fisher Scientific, Inc; Athena Diagnostics; Bio-Rad Laboratories Inc; AbaStar MDX, Inc.; Acumen Pharmaceuticals; BANYAN BIOMARKERS, INC.; and Alseres Pharmaceuticals, Inc. - among others.

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified